Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-18-RHUS-0004, IAHU-0004-PROMETHEUS, JTC_2021, ANR-21-PERM-0005)
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 15 July 2025
First Online: 23 July 2025
Declarations
:
: DA received a grant from Programme Hospitalier de Recherche Clinique 2007 of the French Ministry of Social Affairs and Health (contract P070128) to conduct this study, part of large research program on sepsis, for which DA is supported by public grants “Programme d’Investissements d’Avenir” (PIA), reference ANR-18-RHUS-0004, and France 2030, reference IAHU-0004-PROMETHEUS, and the iRECORDS project, funded by ERA PerMed (JTC_2021) to DA (ANR-21-PERM-0005. DA also received fees for lectures from Baxter, Alexion, Beckman Coulter, and for advisory board from Hillrom, Janssen, Pfizer, Regeneron, Sanofi, Viatris, Volition, and for safety and monitoring board from Fab’entech. Dr. Seymour receives grants from the National Institutes of Health, and consulting fees from Octapharma, Beckman Coulter, Edwards Inc, and travel funds from ISF, ISICEM, and ANZICs. DA is a Section Editor for Intensive Care Medicine. He has not taken part in the review or selection process of this article.
: Not applicable.
Free to read: This content has been made available to all.
